The most studied SIRTs in cancer are SIRT-1, -2, -3 and -6, with modulators that either exhibit an anti-proliferative effect, induce apoptosis, or sensitize cancer cells to existing chemotherapeutics in vitro, or that block tumor growth in vivo. The gene discussed is SIRT1; the disease is neoplasm.